Early-life origin and prevention of chronic obstructive pulmonary diseases

Pediatr Allergy Immunol. 2020 Feb:31 Suppl 24:16-18. doi: 10.1111/pai.13157.

Abstract

Chronic obstructive respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD) have their roots in the womb. Together with a genetic predisposition, prenatal and early-life factors, including maternal smoking, prematurity, and bronchopulmonary dysplasia (BPD), have a pivotal role in later respiratory health. Then, inappropriate responses to respiratory viruses (especially respiratory syncytial virus and rhinovirus) and early allergic sensitization are the strongest contributors to the inception of wheezing and early-onset asthma. There is an urgent need for early disease biomarkers to identify profiles at higher risk of chronic respiratory conditions. Applying the "-omic" technologies to urine, blood and breath condensate, and non-invasive inflammometry seem promising in this regard. The description of specific risk profiles may be the key to the use of targeted personalized therapies.

Keywords: chronic pulmonary diseases; early-life origin; prevention.

MeSH terms

  • Asthma / diagnosis*
  • Asthma / epidemiology
  • Biomarkers / metabolism
  • Bronchopulmonary Dysplasia / diagnosis*
  • Bronchopulmonary Dysplasia / epidemiology
  • Cigarette Smoking / adverse effects
  • Early Diagnosis
  • Female
  • Humans
  • Hypersensitivity / diagnosis*
  • Hypersensitivity / epidemiology
  • Maternal Exposure / adverse effects
  • Pregnancy
  • Prenatal Exposure Delayed Effects / diagnosis*
  • Prenatal Exposure Delayed Effects / epidemiology
  • Pulmonary Disease, Chronic Obstructive / diagnosis*
  • Pulmonary Disease, Chronic Obstructive / epidemiology
  • Respiratory Tract Infections / diagnosis*
  • Respiratory Tract Infections / epidemiology
  • Risk
  • Virus Diseases / diagnosis*
  • Virus Diseases / epidemiology

Substances

  • Biomarkers